Filter
655
Text search:
Zhang,
Y.
Featured
Recommendations
63
New Publications
81
Language
Document type
Studies & Reports
201
No document type
199
Guidelines
181
Manuals
30
Fact sheets
27
Strategic & Response Plan
8
Training Material
4
Situation Updates
2
Infographics
2
Brochures
1
Countries / Regions
Global
35
Russia
34
Brazil
18
Latin America and the Carribbean
15
Germany
13
Middle East and North Africa
13
Africa
12
India
10
South Africa
10
Syria
9
Yemen
9
Eastern Europe and Central Asia
9
Peru
8
Western and Central Europe
8
Spain
8
Mozambique
7
Eastern Europe
7
Philippines
6
Ukraine
6
Ecuador
6
Uganda
5
China
5
Angola
5
Myanmar / Burma
5
Chile
5
West and Central Africa
5
Sierra Leone
4
South Sudan
4
Kenya
4
Sudan
4
Argentina
4
Colombia
4
Paraguay
4
Asia
4
Vietnam
4
Burkina Faso
3
Nigeria
3
Senegal
3
Mali
3
Guinea-Bissau
3
Ethiopia
3
Nepal
3
Indonesia
3
Bangladesh
3
Benin
3
Sri Lanka
3
South–East Asia Region
3
France
3
Congo, Democratic Republic of
2
Ghana
2
Niger
2
Cambodia
2
Botswana
2
Bolivia
2
Mexico
2
East and Southern Africa
2
Venezuela
2
Congo-Brazzaville
2
Tajikistan
2
North America
2
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Saudi Arabia
1
Cameroon
1
Zimbabwe
1
Haiti
1
Somalia
1
Iraq
1
Jordan
1
Lebanon
1
Egypt
1
Chad
1
Tanzania
1
Rwanda
1
Mauritania
1
Malawi
1
Dominican Republic
1
Austria
1
Switzerland
1
Cuba
1
Honduras
1
El Salvador
1
Libya
1
Guatemala
1
Madagascar
1
Lesotho
1
Nicaragua
1
Bhutan
1
North Korea
1
Italy
1
Mongolia
1
Laos
1
Canada
1
Timor Leste/ East Timor
1
Qatar
1
Iran
1
Kyrgyzstan
1
Kazakhstan
1
Mauritius
1
Tunisia
1
Portugal
1
Belarus
1
Israel
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
201
Clinical Guidelines
63
Public Health
59
Women & Child Health
20
Key Resources
12
Pharmacy & Technologies
5
General Guidelines
1
Toolboxes
COVID-19
212
Planetary Health
50
HIV
44
Mental Health
44
NCDs
40
TB
34
NTDs
28
Disability
24
AMR
18
Pharmacy
13
Caregiver
10
Ebola
9
Rapid Response
9
Global Health Education
8
Natural Hazards
6
Health Financing Toolbox
5
Conflict
4
Zika
2
Refugee
1
The document "Global Report on Diabetes" by the World Health Organization (WHO) provides an in-depth analysis of diabetes as a global health challenge. It covers the rising prevalence of the disease, the associated risk factors, and the increasing burden on healthcare systems, particularly in low- a
...
Diabetes is a serious, chronic disease that occurs either when the pancreas does not produce enough insulin (a hormone that regulates blood sugar, or glucose), or when the body cannot effectively use the insulin it produces. Diabetes is an important public health problem, one of four priority noncom
...
The evolving epidemic of type 2 diabetes mellitus has challenged health-care professionals. It stands among the leading causes of mortality in the present world. It warrants new and versatile approaches to improve mortality and the associated huge quality-adjusted life years lost to it once diagnose
...
Terminology used to describe the transmission of pathogens through the air varies across scientific disciplines, organizations and the general public. While this has been the case for decades, during the coronavirus disease (COVID-19) pandemic, the terms ‘airborne’, ‘airborne transmission’ a
...
State of the Climate in Asia 2023
recommended
Asia remained the world’s most disaster-hit region from weather, climate and water-related hazards in 2023. Floods and storms caused the highest number of reported casualties and economic losses, whilst the impact of heatwaves became more severe, according to a new report from the World Meteorolog
...
The document provides detailed clinical guidelines for the therapy of Type 1 Diabetes as developed by the German Diabetes Association (DDG). It focuses on individualized insulin therapy, structured patient training, and monitoring of blood glucose levels. The guidelines emphasize preventing complica
...
The article "Under- and over-diagnosis of COPD: a global perspective" reviews the worldwide variation in the prevalence of chronic obstructive pulmonary disease (COPD) and issues related to its misdiagnosis. It highlights that COPD is under-diagnosed due to factors such as limited access to spiromet
...
Asthma is the most common chronic disease in children, imposing a consistent burden on health system. In recent years, prevalence of asthma symptoms became globally increased in children and adolescents, particularly in Low-Middle Income Countries (LMICs). Host (genetics, atopy) and environmental fa
...
The goal of asthma treatment is to obtain clinical control and reduce future risks to the patient. To reach this goal in children with asthma, ongoing monitoring is essential. While all components of asthma, such as symptoms, lung function, bronchial hyperresponsiveness and inflammation, may exist i
...
The pharmacological management of asthma has changed considerably in recent decades, as it has come to be understood that it is a complex, heterogeneous disease with different phenotypes and endotypes. It is now clear that the goal of asthma treatment should be to achieve and maintain control of the
...
The pharmacological management of asthma has changed considerably in recent decades, as it has come to be understood that it is a complex, heterogeneous disease with different phenotypes and endotypes. It is now clear that the goal of asthma treatment should be to achieve and maintain control of the
...
Aerosol pollutants are known to raise the risk of development of non-communicable respiratory diseases (NCRDs) such as asthma, chronic bronchitis, chronic obstructive pulmonary disease, and allergic rhinitis. Sub-Saharan Africa’s rapid pace of urbanization, economic expansion, and population growt
...
Silicosis is not a new disease; the impact of silica dust on respiratory function was observed by Hippocrates in 430 B.C. and in the 16th century by Agricol. In 1713, Rammazini described silicotic nodules in post-mortems of stone cutters presenting with respiratory symptoms. In the mid-late 1800s,
...
Asbestos, the most frequent cause of occupational cancer, continues to be consumed ona massive scale, with millions of people exposed on a daily basis. This review explains why we havefailed in curtailing the silent epidemic of asbestos-related disease and why the numbers of asbestosvictims are like
...
interim guidance, 25 November 2024
